1800 202 8726
Managing side effects

Acne-Like Rash on EGFR Inhibitors — Why It Happens and How to Treat It

The rash that appears during EGFR inhibitor treatment is not an allergy and not a skin disease. It is a predictable response to how this class of drug works. Most cases are manageable at home — but a few signs mean you need same-day review.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026

  • Expected, not alarming — This rash appears in the majority of people taking EGFR inhibitors. It does not mean the drug is unsafe for you.
  • Not ordinary acne — It looks similar but behaves differently. Standard acne treatments can irritate it further.
  • Infection risk is real — A mild rash that develops signs of infection — pus, spreading redness, pain — needs same-day review.
  • A rash may be a good sign — Some data suggests a visible rash can indicate the drug is active in your body. Your oncologist can explain what this means for you.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a medical oncologist

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Reviewed by a senior medical oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

The rash from EGFR inhibitors is not ordinary acne — it is a predictable skin response to how the drug works. For most people it is mild and manageable with moisturiser, sunscreen and antibiotics your oncologist prescribes. Signs of infection, blistering, or a rash spreading rapidly across your body need same-day medical review.

If a symptom below applies to you, do not wait for a callback. Call 1800-202-8726 or go to your nearest emergency department.

What is this rash and should you be worried?

EGFR inhibitors work by blocking a protein that cancer cells use to grow — but the same protein is active in the skin. When the drug blocks it there too, the skin reacts with papules and pustules that look like acne, usually on the face, scalp, chest and upper back.

This is expected. It is not an allergy, not a sign the drug is wrong for you, and not ordinary acne. NCCN and ASCO guidance classifies it as a predictable, manageable side effect — not a reason to stop treatment on its own.

The concern is not the rash itself but what it can become. Skin that is already inflamed is more vulnerable to infection, and an untreated rash can affect your quality of life and occasionally require a dose adjustment. Reporting early gives your team the most options.

How do you know when the rash needs medical review?

FeatureMild — manage at homeModerate — call todaySevere — go now
Typically startsFirst 1–2 weeks of treatmentCan develop from a mild rash left untreatedAny time; sudden worsening is a warning sign
Skin area affectedSmall patches, mainly face and upper chestSpreading beyond face; affecting daily comfortLarge areas of body, or spreading rapidly
AppearancePimple-like bumps, redness, drynessMore widespread bumps and pustulesBlistering, raw or peeling areas
Signs of infectionNonePossible early signs — watch closelyPresent: warmth, pus, spreading redness, pain
What to doHome care plus team-prescribed antibioticsCall your oncology team the same dayEmergency department now

Not sure what this means for you?

Share your reports and a senior oncologist will explain your options in plain language — no obligation to start treatment.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

What you can do at home for a mild rash

  • Moisturise twice a dayApply a fragrance-free moisturiser morning and night. Dry skin makes the rash more uncomfortable and more prone to cracking.
  • Use sunscreen every dayEGFR inhibitor rash is made worse by sun exposure. Use a broad-spectrum SPF 30 or higher, even indoors near windows.
  • Switch to a gentle, non-soap cleanserOrdinary soap dries and irritates already-sensitive skin. Use a pH-balanced, fragrance-free face wash.
  • Do not pick or squeeze the bumpsBreaking the skin opens a direct route for infection, which is the main risk you are managing.
  • Wear loose, breathable clothingTight fabric rubbing against rash on the chest and back increases irritation.
  • Take antibiotics if your team has prescribed themOral or topical antibiotics are commonly prescribed for this rash. Take the full course even if the rash improves early.
  • Tell your team what products you are already usingSome over-the-counter acne treatments — retinoids, benzoyl peroxide, astringents — will make this rash worse.

Does a rash mean the treatment is working?

Some studies have observed that patients who develop this rash may have better treatment outcomes than those who do not. ASCO acknowledges this correlation in its guidance on EGFR inhibitor toxicities.

What this does not mean: a worse rash is not a goal, and a mild rash is not a failure. The correlation is a population observation, not a reliable predictor for any one person.

If the rash is difficult to manage, tell your oncologist. There are effective treatments for it, and managing the rash does not reduce the benefit of the drug.

Other questions about this rash

Will my oncologist prescribe antibiotics just for a rash?

Yes, and this is standard practice rather than an overreaction. NCCN and ASCO guidance recommends topical antibiotics for mild rash and oral antibiotics for moderate rash. These are prescribed not because the rash is infected but because certain antibiotics reduce skin inflammation in this specific reaction. If you have been prescribed a course and the rash settles, complete it in full before asking whether it can stop — stopping early often allows the rash to return.

The rash is on my scalp. Is that the same condition?

Scalp involvement is common with EGFR inhibitors and is part of the same skin reaction, not a separate problem. It can cause soreness, crusting and sometimes hair changes. Gentle, fragrance-free shampoo usually helps with mild scalp rash. If the scalp is painful, producing pus, or you notice significant hair thinning, tell your oncology team — scalp involvement may need a specific prescription rather than general care.

How long will the rash last?

For most people the rash is most noticeable in the first few weeks of treatment and then stabilises or partially improves. It typically continues for as long as you are on the drug rather than resolving completely. This is worth knowing in advance so that managing it becomes part of your routine rather than a sign something has gone wrong. If it worsens after a period of stability, that change is worth reporting to your team.

Can I wear makeup or cover it up?

Yes, provided the product is non-comedogenic and fragrance-free. Heavy coverage that blocks pores can worsen pustules, and some makeup removers contain alcohol that dries inflamed skin further. Mineral-based products are often better tolerated. If you are unsure about a specific product, ask your oncology nurse or a pharmacist. Avoid trying several new products at once — introduce them one at a time so you can identify any that cause a reaction.

Will my dose be reduced because of the rash?

A dose reduction or temporary treatment pause is sometimes needed for a severe or persistent rash that does not respond to other management. Your oncologist will weigh the severity of the skin reaction against how well the treatment is working for your cancer. This is an active clinical decision, not a failure — many patients resume the full dose once the rash is brought under control. Reporting symptoms early, rather than tolerating them, increases the chance that a dose change will not be necessary.

Explore 108 more Side Effects, Emergencies & Daily Living topics

Side Effects - Symptom-Specific Deep Dives

All Side Effects, Emergencies & Daily Living →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Is the rash from EGFR inhibitors the same as ordinary acne?

It looks similar but it is not the same condition. Ordinary acne is driven by blocked pores and bacterial overgrowth. This rash is driven by the drug blocking a receptor in skin cells that normally regulates repair and renewal. That difference matters for treatment: standard acne products containing benzoyl peroxide, retinoids or alcohol-based astringents can make it worse rather than better. Tell your team what you are already using so they can advise which products are safe.

What antibiotic is used for EGFR inhibitor rash?

The choice — and whether it is a gel applied to the skin or a tablet — depends on how widespread and uncomfortable the rash is, and on other medicines you are already taking. Your oncologist or dermatologist will prescribe the option that fits your situation. Do not use leftover antibiotics from a previous prescription without asking first, because the correct agent, duration and approach differ from those used for ordinary skin infections.

Should I stop my cancer treatment because of the rash?

No, not on your own. Stopping an EGFR inhibitor without medical advice removes the treatment from your cancer while the skin continues to recover on its own timeline. If the rash is severe, your oncology team may recommend a planned dose adjustment or a short pause — that is different from stopping altogether, and it is a decision they make with full information. Contact your team if the rash is distressing. Do not manage it by stopping the drug yourself.

How is this rash different from an allergic reaction to the drug?

An allergic drug reaction typically appears quickly after early doses, often with hives, swelling or difficulty breathing. The EGFR inhibitor rash usually develops over days to weeks, is confined to sun-exposed and oily areas of skin, and does not cause breathing difficulty or widespread swelling. If you develop sudden hives, swelling of the lips or throat, or any breathing difficulty during treatment, that is a separate and urgent situation — go to the emergency department immediately.

Will the rash leave scars or permanent skin changes?

Mild to moderate rash that is managed well generally does not leave lasting marks. Severe or repeatedly infected rash — or rash damaged by picking — has a higher chance of leaving post-inflammatory darkening of the skin, which fades over months, or rarely, scarring. Avoiding picking and treating any infection early are the two things most within your control. If skin changes persist after the rash settles, a dermatology review can advise on management.

Call now Book free consultation